Sort   by:  
 Page size 
UnknownTau Positron Emission Tomographic Findings in a Former US Football Player With Pathologically Confirmed Chronic Traumatic Encephalopathy.
Not available
S-EPMC6990867 | biostudies-literature
Unknown18F-flortaucipir PET to autopsy comparisons in Alzheimer's disease and other neurodegenerative diseases.
Not available
S-EPMC7719031 | biostudies-literature
UnknownEvidence of corticofugal tau spreading in patients with frontotemporal dementia.
Not available
S-EPMC7012377 | biostudies-literature
UnknownEarly neuronal accumulation of DNA double strand breaks in Alzheimer's disease.
Not available
S-EPMC6524256 | biostudies-literature
UnknownFLEXITau: Quantifying Post-translational Modifications of Tau Protein in Vitro and in Human Disease.
Not available
S-EPMC5808556 | biostudies-literature
UnknownTMEM106B protects C9ORF72 expansion carriers against frontotemporal dementia.
Not available
S-EPMC3944829 | biostudies-literature
UnknownVariants in the ATP-binding cassette transporter (ABCA7), apolipoprotein E ϵ4,and the risk of late-onset Alzheimer disease in African Americans.
Not available
S-EPMC3667653 | biostudies-literature
UnknownTMEM106B regulates microglial proliferation and survival in response to demyelination.
Not available
S-EPMC10162677 | biostudies-literature
ProteomicsQuantitative PTM Maps of Human Pathologic Tau Identify Patient Heterogeneity and Define Critical Steps in Alzheimer’s Disease Progression - high/low molecular weight tau
To elucidate the role of Tau isoforms and PTM stoichiometry in Alzheimer’s disease (AD), we generated a high resolution quantitative proteomic map of 88 PTMs on multiple isoforms of Tau isolated from the post-mortem human tissue from 49 AD and 42 control subjects. While Tau PTM maps reveal heterogen...
ORGANISM(S): Homo sapiens (Human) 
2020-12-04 | PXD020483 | Pride
Alzheimer's disease  post-translational modification  clinical progression  srm  lfq  human tau  protein aggregation  proteopathy 
ProteomicsQuantitative PTM Maps of Human Pathologic Tau Identify Patient Heterogeneity and Define Critical Steps in Alzheimer’s Disease Progression - frontal gyrus
To elucidate the role of Tau isoforms and PTM stoichiometry in Alzheimer’s disease (AD), we generated a high resolution quantitative proteomic map of 88 PTMs on multiple isoforms of Tau isolated from the post-mortem human tissue from 49 AD and 42 control subjects. While Tau PTM maps reveal heterogen...
ORGANISM(S): Homo sapiens (Human) 
2020-12-04 | PXD020538 | Pride
Alzheimer's disease  post-translational modification  clinical progression  srm  lfq  human tau  protein aggregation  proteopathy 
Sort   by:  
 Page size